CORONA Remedies has secured Eurasian Economic Union - Good Manufacturing Practices (EAEU-GMP) Certification for its finished dosage facility situated at Bhayla, Gujarat. This certification paves the way for the company’s entry into five EAEU member nations -- Russia, Kyrgyzstan, Armenia, Belarus, and Kazakhstan -- under a B2B business model.
It unlocks access to a pharmaceutical market estimated at $25 billion and aligns seamlessly with the company’s long-term vision of fostering sustainable international partnerships. EAEU-GMP certification further strengthens the company’s focus across its four key therapeutic pillars -- Women’s Health, Cardio-Diabetes, Pain Management, and Urology.
CORONA Remedies is primarily engaged in the business of manufacturing, trading and marketing of pharmaceutical products.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: